Online Articles: Case Report/Small Case SeriesRevision of a Leaking Bleb With XEN Gel Stent ReplacementSalinas, Lauriane MD*; Chaudhary, Ankita MD*; Guidotti, Jacopo MD*; Mermoud, André MD*; Mansouri, Kaweh MD, MPH*,†Author Information *Glaucoma Research Center, Montchoisi Clinic, Swiss Vision Network, Lausanne, Switzerland †Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO Supported in part by the Swiss Glaucoma Research Foundation, Lausanne, Switzerland. Disclosure: K.M and A.M. are consultants for Allergan Inc. The remaining authors declare no conflict of interest. Reprints: Kaweh Mansouri, MD, MPH, Glaucoma Research Center, Montchoisi Clinic, Swiss Vision Network, Lausanne, Switzerland (e-mail: [email protected]). Journal of Glaucoma: January 2018 - Volume 27 - Issue 1 - p e11-e13 doi: 10.1097/IJG.0000000000000811 Buy SDC Metrics Abstract Minimally invasive glaucoma surgery includes different devices which provide a less invasive and safer means of reducing intraocular pressure. The XEN Gel Stent (Allergan Inc., CA) is an ab interno procedure which creates a subconjunctival drainage pathway. It is a new surgical device and there is a paucity of data on complications and their management. We report a clinical case of a leaking bleb after XEN surgery managed by bleb revision, conjunctival suturing, and XEN replacement. Copyright © 2017 Wolters Kluwer Health, Inc. All rights reserved.